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Abstract
Most of the parties involved in healthcare decisions – governments, politicians, healthcare professionals,
pharmaceutical companies, special interest groups – actively work to make their desires known. In Israel the public
is part of the decision committee; in Germany health care decision are made more or less without the public being
involved. In a recently published IJHPR article, Giora Kaplan and Orna Baron-Epel raise the question of how well
acquainted senior decision makers in the Israeli health system are with the public’s priorities regarding the services
being considered for inclusion in the public funding list. This commentary speculates about the reasons for the
discrepancies found in that article between the decision makers’ and the public’s view. Furthermore, it reports on
survey results from Germany about who should be part of the decision making committee and briefly touches
upon the situation in other OECD countries. While public opinion may not be the determining factor, all authors
advocate a strengthening of the public’s contribution to the health care decision making process, including steps
to make decision makers aware of public priorities on an ongoing basis.
Background
New expensive health technologies, an aging population
and changing epidemiology all increase health care ex-
penditures, and as a result, health systems worldwide are
struggling with the need to control costs to maintain
system viability. Priority setting in health-care services
according to some pre-defined criteria is proposed as
one possibility to handle the problem of limited
resources. Most of the parties involved in healthcare
decisions – governments, politicians, healthcare profes-
sionals, pharmaceutical companies, special interest
groups – actively work to make their desires known.
However, despite their obvious interest in setting prior-
ities, it is the patients who will likely have the greatest
difficulty in providing input to these discussions.
If priority-setting decisions are to be accepted, it is
important to include the public in the decision-making
process [7]. The Ljubljana charter on reforming health
care in Europe therefore states that “Health care reforms
must address citizens’ needs, taking into account,
through the democratic process, their expectations
about health and health care” [12]. Legitimizing health
policy decisions involves including both the healthy and
the sick [1,6].
How can the public be included? Sabik and Lie [9]
review priority setting efforts in eight countries (Norway,
Sweden, Israel, the Netherlands, Denmark, New Zealand,
the United Kingdom, and the state of Oregon in the
US). All these countries established specific committees
to set priorities in the 1990’s or so and have restructured
them since. They strongly advocate public involvement
in priority setting in health care but to different degrees.
Norway encourages a public discussion; Denmark offers
public events and distributed material about priority
setting in medicine; New Zealand, the Netherlands,
Oregon, and Sweden include feedback from public
discussion forums and results from surveys in their deci-
sion making process. In England the public can get
involved at various levels and a website (National Insti-
tute for Health and Clinical Excellence, http://www.ni-
ce.org.uk/) offers active participation.
The situation in Israel
In Israel, the National Advisory Committee decides what
should be added to the list of publicly funded health
services, with more than one-third of the committee
members being public representatives [10]. In this
context, Giora Kaplan and Orna Baron-Epel [8] raise the
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question of how well acquainted senior decision makers
in the Israeli health system are with the public’s prior-
ities among the services being considered for inclusion
in the funding list. The research was conducted in two
steps. First, they conducted a phone population survey
regarding the public’s opinion on priorities in health
across a variety of services (e.g. fertility treatments,
cardiac rehabilitation, nursing care, prevention, mental
health). Second, they carried out face-to-face interviews
with senior officials in the main institutions of the Israeli
health care system with respect to their perceived and
expected preferences of the public. The results show a
large discrepancy between the public’s preferences and
the decision makers’ predicted preferences. Before I will
speculate about some reasons for the misjudgments of
the decision makers I describe the situation of public
involvement in Germany.
The situation in Germany
In Germany discussions of priority setting – with or with-
out the public being involved – are carried out mainly in
academia. Several attempts have been made to include
decision makers – particularly physicians and politicians -
without success. Indeed, all ministers of health over the
last decades or so have refused to even talk about this
issue. For those insured under statutory health insurance
(SHI), which is about 90 % of the population, the Federal
Joint Committee (Gemeinsamer Bundesausschuss, G-BA)
makes decisions on healthcare benefits, and it defines
in detail what adequate, appropriate, and economical
healthcare, as defined by law, entails (https://www.g-
ba.de/institution/service/publikationen/gba/).
The Federal Joint Committee (G-BA) consists of five
stakeholder groups with voting rights (three impartial
members; five representatives from the Central Federal
Association of Health Insurance Funds, the organization
representing all statutory health insurance funds; five
representatives from the Central Federal Association of
Health Insurance Funds, the organization representing all
statutory health insurance funds; two representatives from
the National Association of Statutory Health Insurance
Physicians, which includes all licensed physicians and psy-
chotherapists who treat SHI patients; two representa-
tives from the German Hospital Federation, the interest
group representing hospitals; and one representative
from the National Association of Statutory Health
Insurance Dentists, which includes all licensed dentists
who treat SHI patients). Five patient representatives
take part in all plenary sessions, subcommittee meetings,
and workgroup meetings. They are entitled to submit peti-
tions and take part in discussions, but have no right to
vote. This would be the main source of information on
the (sick) public’s preferences. Note, the G-BA decides
which services are brought to the committee and decides
what is eventually funded.
How does the public feel about this? A population
survey (computer assisted personal interviews (CAPI),
n = 2031) was conducted in 2009 addressing thirty-four
questions with 135 items organized into ten health care
and health system related themes (e.g., [4,5]). One
theme was about the decision makers and their func-
tion in distributing health care benefits. The question
and results (percentage of agreement) are shown in the
following Fig. 1.
According to public opinion, representatives of health
insurers (52 %), physicians (84 %) und patients/patient
organization (55 %) should have a right of co-determination,
when deciding what health care services should be paid for
by the statuary health insurance. At the same time, a high
percentage of the public indicate that the following
should have no say: politicians (60 %), representatives
of religious groups/churches (63 %) and economists
(54 %). This is interesting in so far as these stake-














































Representatives of health insurers
Patients/Patient organizations
Physicians
Right of co-determination Advisory function Neither nor NA
Fig. 1 Citizens’ preferred stakeholders’ involvement in medical decision processes. The public’s agreement to the question: “In your opinion who
should take part in decision making when deciding what should be paid by the SHI; who should only have an advisory function; and who
should not have a say at all?” The results are in percentage. NA stand for “no answer given”
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comes to health care services, directly (such as political
programs, e.g. personal responsibility –out of pocket pay-
ment) or indirectly (like ethics committee, e.g. prenatal
diagnosis). Respondents expressed the view that some
stakeholders (representatives from hospitals, nurses, scien-
tists) should rather be co-determining and advisory,
whereas other stakeholders (ethicists and jurists) should
have at most advisory functions. The respondents are
divided when it concerns their own involvement in the de-
cision process. The percentages in all three categories
(right of co-determination; advisory function; neither nor)
are similar. For no other group can we observe a dichot-
omy of “right of co-determination” versus “no function”.
In an “Others” response category (not listed here) the
“general public” and “member of the family” were men-
tioned. This suggests that some of the respondents as-
sumed only selected citizens for the category “citizens”
and not the general public. Obviously, also here we can
observe a discrepancy between the public’s opinion and
the policies employed.
Possible reasons for decision makers’
misperceptions of public preferences and possible
remedies
Kaplan and Baron-Epel contemplate several possible
reasons for the lack of accuracy in the decision makers’
predictions on public’s preferences, which include
ignoring the input of the public and misinterpreting in-
formation presented in the media. The latter could be
due to a cognitive bias [11]: If the media report on one
particular issue very often, e.g., hospitalization in a pri-
vate hospital, the decision maker might get the impres-
sion that this is highly rated in the public’s opinion.
Furthermore, it is possible that the decision makers
exhibit a self-serving bias; they may be projecting their
own preferences onto the public’s view.
How can we involve the public better, elicit reliable
opinions, and increase decision maker awareness of
public preferences? For the general public, representa-
tive surveys are a means – basically the only means.
The argument that they are invalid would also be true
for general elections. Over the last decade or so, several
representative surveys have been conducted in several
countries. The results are mostly discussed in academic
communities only; decision makers should be willing to
consult them, and their exposure to public survey re-
sults should be a part of the decision making process.
Town hall meetings and focus groups are applicably
only for specific topics with very few participants. They
might provide additional information but always face
the problem of legitimacy (if not elected). Web based
discussion forums like NICE in the UK are another
source of information about the public’s preferences re-
garding health care services.
The opposition to public involvement
But there are also opponents to public involvement.
Bruni et al. [1] list frequently cited reasons for why
citizens are (and should be) excluded from the decision
process, one being the lack of objectivity and self-
serving biases. However, there is no reason to assume
that this is different from other stakeholder groups in-
volved in setting priorities in health care, such as physi-
cians, hospital representatives, or representatives from
pharmaceutical companies. And the study by Kaplan
and Baron-Epel supports this. For instance, citizens
prioritized cardio-rehabilitation, which deems to be very
reasonable when it comes to surviving or not, whereas
the decision makers prioritized fertility treatment, which
might reflect a particular ethical/religious attitude.
Another argument is the belief that the public’s lack of
knowledge about scientific, clinical, and administrative
aspects of health care means they cannot contribute
meaningfully to priority setting. However, as Bruni et al.
[1] point out, the public has real-life experience as users
of the health care system and can offer insight into the
values and beliefs of the public at large.
In agreement with Kaplan and Baron-Epel, I strongly
support public involvement when it comes to setting
priorities in health care. After all, it is the public which
finances the health system (by premiums and taxes) and
primarily uses the services; they are the largest and most
important stakeholder group. The Israeli process in
which public involvement is guaranteed by the compos-
ition of the Advisory Committee - even if the list of pre-
ferred benefits needs to be debated - seems to merit
acceptance from the Israeli public and physicians [2,3].
At the same time, we cannot assume that the “public
representatives” appointed by Israel’s Minister of Health
will responsibly and accurately give voice to the prior-
ities of the general public; much depends on how they
are selected and whether, as Kaplan and Baron-Epel
suggest, they are provided with periodic and systematic
data about public preferences.
Conclusions
The comparison between Germany and Israel suggests
that citizen views on priority setting should be ad-
dressed by policy makers in two layers. The first layer
is to recognize that citizens have preferences and
desire citizen input into decision making processes.
The second is to ensure that decision makers are
aware of public preferences and public views on im-
portant decisions. This requires involving public rep-
resentatives in the decision making process, ongoing
gathering of data from the public, passing the data
onto decision makers, and re-checking citizen views
on priority setting decisions and the process by which
these are made.
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